ICE-HBV is delighted to endorse the 5th ANRS workshop on HBV cure which will be held in Paris on 10 April 2018. The programme can be found here.
We will have a booth at the International Liver Congress, please visit us during exhibition times on booth #822, just next to EASL community hub.
Experts will be there during morning breaks to present our work and answer your questions. See the programme:
Pr. Anna Kramvis and Dr. Wenhui Li are joining ICE-HBV Governing Board as representatives for Africa and Asia.
Read more about them here:
ICE-HBV is delighted to announce that Joan Block, Co-Founder of the Hepatitis B Foundation, is joining the Governing Board as first community representative.
More about Joan here.
ICE-HBV took part in the World Hepatitis Summit in Sao Paulo on November 1-3, 2017, joining 900 delegates from all over the world. The World Hepatitis Summit is a large-scale, global biennial event to advance the viral hepatitis agenda. It is a joint initiative between World Health Organization (WHO) and the World Hepatitis Alliance – in collaboration with a different host country for each Summit.
Among others news, WHO announced that in 2.8 million additional people starting lifelong treatment for hepatitis B in 2016 was a marked increase from the 1.7 million people starting it in 2015.
ICE-HBV presented a poster and held an international consultation on its scientific priorities and governance systems, attended by delegates from five continents (picture). ICE-HBV was also presented by ANRS as part of the plenary presentation by Prof. Christian Trepo.
ICE-HBV Poster at the World Hepatitis Summit 2017
ICE-HBV at the World Hepatitis Summit 2017
The HBV Cure Workshop is a scientific platform that acts as a catalyst to accelerate the progress for achieving a cure. This meeting will bring together the world’s leading basic, translational and clinical experts to share and discuss the latest research outcomes and challenges.
ICE-HBV members Stephen Locarnini and Harry Janssen are chairing the workshop, and many more will be speaking about their research towards an HBV cure! Find the programme here.
ICE-HBV is growing and developing new organisational policies: you can find the confidentiality policy and industry engagement policy under Publications.
Governance structure and systems are being revised too, in consultation with our stakeholders.
ICE-HBV members T. Jake Liang and Anna Kramvis hosted the 2017 International HBV Meeting in on September 3-7 in Washington D.C., USA.
ICE-HBV Annual Scientific assembly was he held there on September 7.
Dr. Francis Chisari will receive the inaugural Distinguished Award in Hepatitis B Research.
Find out more: http://www.hbvmeeting.org/
Capucine Penicaud is presenting ICE-HBV at the Australasian Viral Hepatitis Elimination Conference on August 10 in Cairns, Australia.
Find her presentation in the online programme.
Stephen Locarnini is presenting ICE-HBV on August 8 at the World Indigenous Peoples’ Conference on Viral Hepatitis in Anchorage, Canada.